New Releases from NCBI BookshelfGuselkumab for treating active psoriatic arthritis after inadequate response to DMARDs.Guselkumab for treating active psoriatic arthritis after inadequate response to DMARDs.
Post Content
Uncategorized
Uncategorized
New Releases from NCBI BookshelfComparing Two Programs to Maintain Weight Loss among Black Women with Obesity [Internet].Comparing Two Programs to Maintain Weight Loss among Black Women with Obesity [Internet].
Black women have the highest prevalence of obesity (56.6%) in the United States. The US Preventive Services Task Force recommends
Uncategorized
New Releases from NCBI BookshelfAbemaciclib with endocrine therapy for adjuvant treatment of hormone receptor-positive, HER2-negative, node-positive early breast cancer at high risk of recurrence.Abemaciclib with endocrine therapy for adjuvant treatment of hormone receptor-positive, HER2-negative, node-positive early breast cancer at high risk of recurrence.
Post Content
Uncategorized
New Releases from NCBI BookshelfAlpelisib with fulvestrant for treating hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancer.Alpelisib with fulvestrant for treating hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancer.
Post Content
Uncategorized
New Releases from NCBI BookshelfDuvelisib for treating relapsed or refractory chronic lymphocytic leukaemia after 2 or more treatments (terminated appraisal) .Duvelisib for treating relapsed or refractory chronic lymphocytic leukaemia after 2 or more treatments (terminated appraisal) .
Post Content
Uncategorized
New Releases from NCBI BookshelfComparing Online and In-Person Family Therapy for Teens with Traumatic Brain Injury and Their Parents [Internet].Comparing Online and In-Person Family Therapy for Teens with Traumatic Brain Injury and Their Parents [Internet].
Traumatic brain injury (TBI) in children contributes to significant morbidity and family burden. Persistent behavioral problems are common, yet many
Uncategorized
New Releases from NCBI BookshelfComparing Two Medicines for Adults with Myasthenia Gravis – The PROMISE-MG Study [Internet].Comparing Two Medicines for Adults with Myasthenia Gravis – The PROMISE-MG Study [Internet].
Myasthenia gravis (MG) is an autoimmune neuromuscular disease caused by autoantibodies directed at the neuromuscular junction. The estimated prevalence is
